Revenue
2019
2020
2021
2022
2023
2024
2025
Quoin Pharmaceuticals, Ltd. (QNRX)
Price$7.01Cached quote
Net income
2017
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2019
2020
2021
2022
Total cash / debt
CashTotal debt
2015
2016
2017
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — |
| Research & development | $9.8M | $3.6M | $3.3M | $2.7M | $1.6M | $244,155 | $45,650 | — | $3.3M | — | — |
| Operating expenses | $16.3M | $9.5M | $9.4M | $9.3M | $6.1M | $1.7M | $1.6M | — | $7.0M | — | — |
| Operating income | −$16.3M | −$9.5M | −$9.4M | −$9.3M | — | −$4.4M | −$6.5M | — | −$7.0M | — | — |
| EBITDA | −$16.2M | −$9.4M | −$9.3M | −$8.6M | — | −$4.2M | −$6.4M | — | −$6.9M | — | — |
| Net income | −$15.8M | −$9.0M | −$8.7M | −$9.4M | −$21.5M | −$2.1M | −$1.6M | — | −$8.1M | — | — |
| Basic EPSper basic share | -$14.80 | -$66.85 | -$337.47 | -$1,638.23 | -$0.00 | -$0.03 | -$0.02 | — | $0.00 | — | — |
| Diluted EPSper diluted share | -$14.80 | -$66.85 | -$337.47 | -$1,638.23 | -$0.00 | -$0.03 | -$0.02 | — | $0.00 | — | — |
Owners
Reported shareholders
≈0.86%of listed shares
Myers Michael602.81K shares · Dec 23, 2024
View holders
| Holder | % owned |
|---|---|
Myers Michael | ≈0.86%602.81K shares |
Carter Denise P. | ≈0.86%602.65K shares |
Dauntless Investment Group, LLC | 0.31%214.99K shares |
Ikarian Capital, LLC | 0.30%211.54K shares |
Stonepine Capital Management, LLC | 0.28%199.49K shares |
Dunn Gordon | ≈0.21%151.08K shares |
MILLENNIUM MANAGEMENT LLC | 0.16%112.32K shares |
Culverwell Anthony James | ≈0.14%100.32K shares |
SummitTX Capital, L.P. | 0.14%100.3K shares |
Woodline Partners LP | 0.11%76.45K shares |
Aberdeen Group plc | 0.11%75K shares |
Soleus Capital Management, L.P. | 0.10%72.73K shares |
AIGH Capital Management LLC | 0.10%70K shares |
BOOTHBAY FUND MANAGEMENT, LLC | 0.09%59.84K shares |
Velan Capital Investment Management LP | 0.05%32.37K shares |
BARCLAYS PLC | 0.03%21.47K shares |
Birchview Capital, LP | 0.03%20K shares |
XTX Topco Ltd | 0.02%15.01K shares |
MORGAN STANLEY | 0.01%8K shares |
UBS Group AG | <0.01%6.77K shares |
Percentages use 70.29M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 14, 2025Form 4 | LANGER DENNISDirector | BuyADSs | 15.2K | $8.49 | $128.6K | 15.2K |
| Oct 14, 2025Form 4 | LANGER DENNISDirector | BuySeries K Warrants (Right to Buy) · derivative | 15.2K | — | — | 15.2K |
| Oct 14, 2025Form 4 | LANGER DENNISDirector | BuySeries J Warrants (Right to Buy) · derivative | 15.2K | — | — | 15.2K |
| Oct 14, 2025Form 4 | LANGER DENNISDirector | BuySeries I Warrants (Right to Buy) · derivative | 15.2K | — | — | 15.2K |
| Oct 14, 2025Form 4 | LANGER DENNISDirector | BuySeries H Warrants (Right to Buy) · derivative | 15.2K | — | — | 15.2K |